Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence of an expanded somatic blood-cell clone in persons without other hematologic abnormalities, is common among older persons and is associated with an increased risk of hematologic cancer. We previously found preliminary evidence for an association between CHIP and atherosclerotic cardiovascular disease, but the nature of this association was unclear. METHODS: We used whole-exome sequencing to detect the presence of CHIP in peripheral-blood cells and associated such presence with coronary heart disease using samples from four case-control studies that together enrolled 4726 participants with coronary heart disease and 3529 controls. To assess causality, we perturbed the function of Tet2, the second most commonly mutated gene linked to clonal hematopoiesis, in the hematopoietic cells of atherosclerosis-prone mice. RESULTS: In nested case-control analyses from two prospective cohorts, carriers of CHIP had a risk of coronary heart disease that was 1.9 times as great as in noncarriers (95% confidence interval [CI], 1.4 to 2.7). In two retrospective case-control cohorts for the evaluation of early-onset myocardial infarction, participants with CHIP had a risk of myocardial infarction that was 4.0 times as great as in noncarriers (95% CI, 2.4 to 6.7). Mutations in DNMT3A, TET2, ASXL1, and JAK2 were each individually associated with coronary heart disease. CHIP carriers with these mutations also had increased coronary-artery calcification, a marker of coronary atherosclerosis burden. Hypercholesterolemia-prone mice that were engrafted with bone marrow obtained from homozygous or heterozygous Tet2 knockout mice had larger atherosclerotic lesions in the aortic root and aorta than did mice that had received control bone marrow. Analyses of macrophages from Tet2 knockout mice showed elevated expression of several chemokine and cytokine genes that contribute to atherosclerosis. CONCLUSIONS: The presence of CHIP in peripheral-blood cells was associated with nearly a doubling in the risk of coronary heart disease in humans and with accelerated atherosclerosis in mice. (Funded by the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“That subjects with clonal hematopoiesis are more susceptible to develop nonhematological, most notably cardiovascular, disease”
From Aging of hematopoietic stem cells (2018) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings are supported by recent findings demonstrating a causal link between mutations in HSPCs in the context of clonal hematopoiesis with indeterminate origin and altered transcriptional output of macrophages, which affect the vascular wall and contributes to atherosclerosis.83,84”
From Inflammatory bone marrow microenvironment (2019) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As CHIP-associated mutations are known to alter the development and function of myeloid cells”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tet2 and Ppm1d mutant murine models have demonstrated an increased inflammatory signature in mutant macrophages, with heightened inflammatory cytokine production upon pro-inflammatory stimulation in vitro [31,32,69,70].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated IL-8 and IL-1β levels have been reported in patients with TET2 CH in the Pakistan Risk of Myocardial Infarction Study (PROMIS) [20,32]”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [32]
Experimental — accuracy not yet measured
38 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Self-citationMacrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Self-citationAge-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339
Cited by
Items 901–1,000 of 1,015
Goldsmith, S. R., Shouse, G., Wong, F. L., Bosworth, A., Iukuridze, A., Chen, S., Rhee, J., Mei, M. G., Htut, M., Janakiram, M., et al. (2024) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2024.06.008 · Cited by 29
Ismail, W. M., Fernandez, J. A., Binder, M., Lasho, T. L., Kim, M., Geyer, S. M., Mazzone, A., Finke, C. M., Mangaonkar, A. A., Lee, J., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014467 · Cited by 26
Fu, M., Lan, Z., Ye, Y., Gong, Y., Liang, Q., Li, M., Feng, L., Chen, A., Dong, Q., Li, Y., et al. (2025) · Kidney International · doi:10.1016/j.kint.2025.04.016 · Cited by 27
Haematopoietic ageing in health and lifespan
Andersson, R., Mejía-Ramírez, E., & Florian, M. C. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01739-1 · Cited by 29
“In some instances a direct mechanistic link between CHIP and the development of cardiovascular disease has been shown 105,119 , but other features of the aged immune system also contribute to cardiovascular disease, such as the role senescent macrophages play in the development of atherosclerotic…”
Kipfer, B., Daikeler, T. D., Kuchen, S., Hallal, M., Andina, N. D., Allam, R., & Bonadies, N. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.05.002 · Cited by 24
“[15] Jaiswal S , Natarajan P , Silver AJ , Gibson CJ , Bick AG , Shvartz E , et al.”
BackgroundEpigenetic Changes as a Target in Aging Haematopoietic Stem Cells and Age-Related Malignancies
Buisman, S. C., & de Haan, G. (2019) · Cells · doi:10.3390/cells8080868 · Cited by 27
Dorsheimer, L., Aßmus, B., Rasper, T., Ortmann, C. A., Abou‐El‐Ardat, K., Kiefer, K. C., Hoffmann, J., Seeger, F. H., Bonig, H. B., Dimmeler, S., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.224402 · Cited by 24
“CHIP has gained enormous medical interest since the prevalence of CHIP is age-dependent and associated with decreased overall survival,(2) which is only partly caused by a moderate risk to develop hematologic malignancies,(1,2) but rather caused by cardiovascular diseases.(8) Atherosclerosis is accelerated in patients…”
BackgroundClonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis
Wang, S., Paşca, S., Post, W. S., Langan, S. J., Pallavajjalla, A., Haley, L. M., Gocke, C. D., Budoff, M. J., Haberlen, S., Brown, T. T., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003280 · Cited by 24
“themechanism for their effect on CAD and aging [21,22].”
BackgroundInfluentialZheng, P., Zou, Q., Chen, L.-Z., Liu, P., Liu, Z.-Y., & Pan, H.-W. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03517-1 · Cited by 25
“Along with increased popularization and application of gene chip gene-chip sequencing technology, microarray analysis has become a practical and novel method of identifying susceptive genes correlated with AMI [11], thus helping clinicians gain a deeper understanding of the relationship between genes and disease [12,…”
MethodTelomere Length: Implications for Atherogenesis
Yin, H. R., & Pickering, J. G. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01082-6 · Cited by 29
TET2 mutation as prototypic clonal hematopoiesis lesion
Guarnera, L., & Jha, B. K. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.01.013 · Cited by 29
Filipek-Gorzała, J., Kwiecińska, P., Szade, A., & Szade, K. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1308709 · Cited by 27
What is pre‐fibrotic myelofibrosis and how should it be managed in 2018?
Curto‐García, N., Ianotto, J., & Harrison, C. N. (2018) · British Journal of Haematology · doi:10.1111/bjh.15562 · Cited by 24
Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms
Asada, S., & Kitamura, T. (2018) · International Journal of Hematology · doi:10.1007/s12185-018-2563-7 · Cited by 26
Huang, Z., Tian, G., Cheng, S., Zhao, D., Zhang, Y., Jia, Y., & Zhou, F. (2018) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x18500921 · Cited by 24
Amorós-Pérez, M., & Fuster, J. J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.008 · Cited by 24
The mitochondrial metabolic checkpoint in stem cell aging and rejuvenation
Mu, W., Ohkubo, R., Widjaja, A., & Chen, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111254 · Cited by 26
Aging, hematopoiesis, and the myelodysplastic syndromes
Chung, S. S., & Park, C. Y. (2017) · Hematology · doi:10.1182/asheducation-2017.1.73 · Cited by 27
“Indeed, this hypothesis is supported by recent studies in which patients with clonal hematopoiesis with mutations in genes, including DNMT3A, TET2, ASXL1, and JAK2, exhibit increased all-cause mortality largely attributable to vascular disease,(31-33) and hypercholesteremia-prone mice engrafted with BM from Tet2-delet…”
BackgroundPoisa-Beiro, L., Thoma, J., Landry, J., Sauer, S., Yamamoto, A., Eckstein, V., Romanov, N., Raffel, S., Hoffmann, G. F., Bork, P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68396-2 · Cited by 23
Systemic and local regulation of hematopoietic homeostasis in health and disease
Carpenter, R. S., & Maryanovich, M. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00482-4 · Cited by 28
“Countless other studies have shown that CH-related mutations worsen outcomes in mouse models of CVD-related diseases by generating hyperactive myeloid cells with elevated IL-1 signaling, strengthening the link between inflammation, CH and CVD 169,170 .”
Hiraiwa, H., Yura, Y., Okumura, T., & Murohara, T. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10418-6 · Cited by 27
“…(CHIP) were shown to have a 1.9-fold increased risk of heart disease compared with non-carriers, and somatic mutations in DNA methyl-transferase DNMT3A , DNA demethylase TET2 , additional sex combs-like 1 ASXL1 , and Janus kinase 2 JAK2 have been associated with ischemic heart disease [34].”
BackgroundInfluentialCHIP: a clonal odyssey of the bone marrow niche
Schleicher, W. E., Hoag, B., Dominici, M. D., DeGregori, J. V., & Pietras, E. M. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180068 · Cited by 24
“CHIP is likewise associated with an increased risk for several aging-associated diseases, including solid cancers, heme malignancies, a variety of heart and lung conditions, and all-cause mortality (1, 6–14).”
BackgroundClonal Hematopoiesis and Risk of New-Onset Myocarditis and Pericarditis
Schuermans, A., Flynn, S., Niroula, A., Uddin, M. M., Sinnaeve, P., Budts, W., Conrad, N., Ebert, B. L., Libby, P., Lin, A. E., et al. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.3369 · Cited by 24
Self-citationChasing ctDNA in Patients With Sarcoma
Coombs, C. C., Dickherber, T., & Crompton, B. D. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280749 · Cited by 25
Lim, J.-Y., Duttke, S. H. C., Baker, T. S., Lee, J., Gambino, K. J., Venturini, N. J., Ho, J., Zheng, S., Fstkchyan, Y. S., Pillai, V., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202733 · Cited by 25
“Understandingwhether and how DNMT3A haploinsufficiency impacts function of the affected immune cells has high public health significance because of (1) the high prevalence of DNMT3A mutations in age-related CH and the world’s rapidly aging population and (2) the association of CH with increased mortality and atheroscl…”
BackgroundInfluentialMyelodysplastic Syndromes and Metabolism
Balaian, E., Wobus, M., Bornhäuser, M., Chavakis, T., & Sockel, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011250 · Cited by 24
“Over the last years, clonal hematopoiesis has been considered a distinct risk factor for the development of cardiovascular disorders, such as ischemic heart disease [84].”
BackgroundResultEmerging Concepts of Vascular Cell Clonal Expansion in Atherosclerosis
Misra, A., Rehan, R., Lin, A., Patel, S., & Fisher, E. A. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316093 · Cited by 25
Higher red cell distribution width and poorer hospitalization‐related outcomes in elderly patients
Kim, K. M., Nerlekar, R., Tranah, G. J., Browner, W. S., & Cummings, S. R. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17819 · Cited by 23
“Clonal hematopoiesis, which increases with aging, also leads to greater variability of RBC and is known to be related to risks of occurrence of chronic diseases.(39,40) Although the exact mechanism that underlies these links remains to be further addressed, a higher RDW value can indicate more vulnerable and less resi…”
BackgroundPoredoš, P., Šabovič, M., Mijovski, M. B., Starčević, J. N., Antignani, P. L., Paraskevas, K. I., Mikhailidis, D. P., & Blinc, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231912054 · Cited by 24
“Age-related somatic mutations in hematopoietic stem cells may result in clonal hemopoiesis of indeterminate significance (CHIP), which increases the risk of hematologic malignancies, CVD and overall mortality [98,99].”
BackgroundSomatic genetic variation in healthy tissue and non-cancer diseases
Solís-Moruno, M., Batlle-Masó, L., Bonet, N., Aróstegui, J. I., & Casals, F. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01213-8 · Cited by 25
“Also, the presence of CHIP almost doubles the risk of having coronary heart disease and makes the risk of myocardial infarction four times higher [45].”
BackgroundMolecular Pathogenesis of Myeloproliferative Neoplasms
Rolles, B., & Mullally, A. (2022) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-022-00685-1 · Cited by 25
Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis
Polizio, A. H., Park, E., & Walsh, K. X. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01083-5 · Cited by 27
Kim, M. J., Song, H., Koh, Y., Lee, H., Park, H. E., Choi, S. H., Yoon, J. W., & Choi, S.-Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1181879 · Cited by 23
“CHIP has been reported to be associated with an increased risk of cardiovascular disease, including coronary heart disease and stroke, and higher mortality (8, 9).”
BackgroundCells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice
Molnár, A., Pásztor, D. T., Tarcza, Z., & Merkely, B. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417129 · Cited by 27
“Previous studies showed, that TET2 or JAK2 clonal mutation increases IL-6 and IL-1 β production in myeloid cells supporting accelerated atherosclerosis [112–114].”
BackgroundInfluence of sleep on physiological systems in atherosclerosis
Kiss, M. G., Cohen, O., McAlpine, C. S., & Świrski, F. K. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00560-7 · Cited by 25
“Clonal hematopoiesis, a premalignant expansion of often deleterious hematopoietic stem cell clones, results from somatic mutations common in epigenetic modifiers, such as Tet2 or Dmnt3a, and increased risk of CVD twofold 243 .”
Arahata, M., & Asakura, H. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s174896 · Cited by 26
“Aging could become the single most important risk factor for arteriosclerosis, owing to the accumulation of genetic mutations.(8,9) Consequently, elderly people have Correspondence: Masahisa Arahata Department of Hematology, Graduate School of Medicine of Kanazawa University, 13-1 Takaramachi Kanazawa, Ishikawa 920-86…”
Park, D. S., Akuffo, A. A., Muench, D. E., Grimes, H. L., Epling‐Burnette, P. K., Maini, P. K., Anderson, A. R. A., & Bonsall, M. B. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006913 · Cited by 25
Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
Sankar, K. N., Stein, B. L., & Rampal, R. K. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-20315-3_11 · Cited by 24
Hoermann, G., Greiner, G., Griesmacher, A., & Valent, P. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030094 · Cited by 24
“In the future, WES or WGS with high coverage could allow for simultaneously testing for both types of genetic variants with a sufficient analytical sensitivity for the detection of CHIP.”
BackgroundResultInfluentialThe clinical implications of clonal hematopoiesis in hematopoietic cell transplantation
Nawas, M. T., Schetelig, J., Damm, F., Levine, R. L., Perales, M., Giralt, S., van den Brink, M. R. M., Arcila, M. E., Zehir, A., Papaemmanuil, E., et al. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100744 · Cited by 23
“In the past few years, CH has been studied in the general population [3,4,6,7], in solid tumor patients undergoing oncologic therapy [12], and in patients prior to leukemic transformation [4] and upon remission [13–16].”
BackgroundInfluentialImpact of age on coronary artery plaque progression and clinical outcome: A PARADIGM substudy
Kim, M., Lee, S., Kwak, S., Yang, S., Kim, Y.-J., Andreini, D., Al-Mallah, M. H., Budoff, M. J., Cademartiri, F., Chinnaiyan, K. M., et al. (2020) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2020.09.009 · Cited by 23
Papo, M., Friedrich, C., Delaval, L., de BOYSSON, H., Viallard, J., Bachmeyer, C., Sené, T., Humbert, S., Duffau, P., Contis, A., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab337 · Cited by 23
Aivalioti, M. M., Bartholdy, B. A., Pradhan, K., Bhagat, T. D., Zintiridou, A., Jeong, J. J., Thiruthuvanathan, V. J., Pujato, M., Paranjpe, A., Zhang, C., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0226 · Cited by 22
“ARCH contributes to several age-related pathologic conditions, including atherosclerosis (2), cardiovascular disease (3), vascular complications (4), and increased risk for developing hematologic malignancies (5, 6).”
BackgroundImpact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma
Gustine, J. N., Branagan, A. R., Cirstea, D. D., Rexha, F., Han, R., Yee, A. J., Maus, M. V., Frigault, M. J., & Raje, N. S. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025015981 · Cited by 24
Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells
Kandarakov, O. F., & Belyavsky, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217902 · Cited by 22
“In addition to the highly elevated risk of venous thrombotic events in carriers of JAK2V671F allele, a strikingly high, about 12-fold, increase in the risk of coronary artery disease is associated with this mutation [30], significantly higher than for mutations in three genes discussed above.”
BackgroundResultInfluentialWudhikarn, K., Padrnos, L. J., Lasho, T. L., LaPlant, B. R., Kumar, S. K., Dispenzieri, A. A., Lacy, M. Q., Rajkumar, S. V., Gertz, M. A., Mangaonkar, A. A., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26125 · Cited by 22
“To the Editor: Clonal hematopoiesis of indeterminate potential (CHIP) is defined by the age-dependent accumulation of somatic leukemia-associated driver mutations in hematopoietic stem cells, in individuals with normal blood counts and with absence of an underlying myeloid neoplasm (MN).(1,2) CHIP is associated with a…”
BackgroundIto, M., Nakano, M., Ariyama, H., Yamaguchi, T., Tanaka, R., Semba, Y., Sugio, T., Miyawaki, K., Kikushige, Y., Mizuno, S., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215597 · Cited by 23
Mechanisms of Post-critical Illness Cardiovascular Disease
Owen, A., Patel, J. M., Parekh, D., & Bangash, M. N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.854421 · Cited by 23
“CHIP is also associated with age, being highly prevalent above the age of 60 years, coupled with an increased incidence of cardiovascular disease (276).”
BackgroundCHIPing away the progression potential of CHIP: A new reality in the making
Xie, Z., & Zeidan, A. M. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.101001 · Cited by 23
Mądry, K., Lis, K., Fenaux, P., Bowen, D., Symeonidis, A. S., Mittelman, M., Stauder, R., Čermák, J., Sanz, G. F., Hellström‐Lindberg, E., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18542 · Cited by 23
“The article is based on data from the European MDS Registry (www.EUMDS.org).”
BackgroundInfluentialCauses of Clonal Hematopoiesis: a Review
Joo, L., Bradley, C. C., Lin, S. H., Scheet, P. A., & Nead, K. T. (2023) · Current Oncology Reports · doi:10.1007/s11912-023-01362-z · Cited by 26
Bewersdorf, J. P., Xie, Z., Bejar, R. L., Borate, U., Boultwood, J., Brunner, A. M., Buckstein, R. J., Carraway, H. E., Churpek, J. E., Daver, N. G., et al. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101072 · Cited by 24
Stelmach, P., Richter, S., Sauer, S., Fabre, M. A., Gu, M., Rohde, C., Janssen, M., Liebers, N., Proynova, R., Weinhold, N., et al. (2023) · Haematologica · doi:10.3324/haematol.2023.282992 · Cited by 23
Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications
Nathan, D. I., Dougherty, M. L., Bhatta, M., Mascarenhas, J. O., & Marcellino, B. K. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104187 · Cited by 24
Mouhieddine, T. H., Nzerem, C., Redd, R. A., Dunford, A. J., Leventhal, M. J., Sklavenitis‐Pistofidis, R., Tahri, S., El‐Khoury, H., Steensma, D. P., Ebert, B. L., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0093 · Cited by 22
“We also identified associations between presence of CH and risk of cardiovascular disease as well as recurrent infections, consistent with prior reports, suggesting that the presence of CH may be associated with increased non-multiple myeloma morbidity (22, 45–47).”
BackgroundResultSelf-citationSensitivity to targeted UBA1 inhibition in a myeloid cell line model of VEXAS syndrome
Chiaramida, A., Obwar, S. G., Nordstrom, A. E. H., Ericsson, M., Saldanha, A. L., Ivanova, E. V., Griffin, G. K., Khan, D. H., & Belizaire, R. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010531 · Cited by 25
Clonal hematopoiesis and autoimmunity
Kishtagari, A., Corty, R. W., & Visconte, V. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.01.012 · Cited by 24
Jentzsch, M., Schwind, S., Bach, E., Stasik, S., Thiede, C., & Platzbecker, U. (2019) · Cancers · doi:10.3390/cancers11111625 · Cited by 24
“4% of individuals older than 90 years, but only 1% of those younger than 50 years) [33,78].”
BackgroundImmune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy
Sava, R., Pepine, C. J., & March, K. L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010241 · Cited by 23
“MSCs support tissue and vascular repair, by producing growth factors such as VEGF, HGF, bFGF, angiopoietin-1 and CXCL10 [36,37].”
BackgroundInfluentialAutoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms
Bekele, D. I., & Patnaik, M. M. (2020) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2020.03.001 · Cited by 22
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
Gurnari, C., Fabiani, E., Falconi, G., Travaglini, S., Ottone, T., Cristiano, A., & Voso, M. T. (2021) · Biology · doi:10.3390/biology10020128 · Cited by 24
“In a large cohort of 4726 individuals with coronary heart disease and 3529 controls deriving from four case–control studies, Jaiswal et colleagues [8] showed that CHIP carriers had a hazard ratio (HR) for myocardial events 1.”
BackgroundVEXAS Syndrome and Disease Taxonomy in Rheumatology
Grayson, P. C., Beck, D. B., Ferrada, M. A., Nigrovic, P. A., & Kastner, D. L. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42258 · Cited by 22
Greenfield, G., & McMullin, M. F. (2018) · Thrombosis Journal · doi:10.1186/s12959-018-0187-z · Cited by 22
Combined landscape of single-nucleotide variants and copy-number alterations in clonal hematopoiesisPreprint
Saiki, R., Momozawa, Y., Nannya, Y., Nakagawa, M. M., Ochi, Y., Yoshizato, T., Terao, C., Kuroda, Y., Shiraishi, Y., Chiba, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.05.433727 · Cited by 22
Clonal haematopoiesis and atherosclerosis: a chicken or egg question?
Sánchez‐Cabo, F., & Fuster, J. J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00554-z · Cited by 22
Dowaidar, M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3nwzd · Cited by 26
Herrera, D. A., Pradhan, K., Snyder, R. B., Karanth, S. S., Janakiram, M., Mantzaris, I., Braunschweig, I., Budhathoki, A., Shah, U. A., Verma, A. K., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0673-8 · Cited by 21
Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat
Baker, J., Shank-Coviello, J., Zhou, B., Dixon, J. K., McCorkle, R. C., Sarpong, D. F., Medoff, E., COOPER, D. L., Seropian, S., & Dai, F. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2019.12.027 · Cited by 23
Green, H. L. H., & Brewer, A. C. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00848-y · Cited by 22
“A recent study also revealed that TET2 is one of the most commonly mutated genes in peripheral blood cells of individuals with clonal haematopoiesis (benign clonal expansion of blood cells), which associated with a higher incidence of atherosclerosis (assessed as coronary artery calcification), myocardial infarction a…”
BackgroundGenomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice
Lee, J., Godfrey, A. L., & Nangalia, J. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100708 · Cited by 22
Clonal Hematopoiesis and Liquid Biopsy in Gastrointestinal Cancers
Croitoru, V. M., Cazacu, I. M., Popescu, I., Paul, D., Dima, S., Croitoru, A. E., & Tănase, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.772166 · Cited by 24
“There is evidence of an increased risk of myeloid neoplasms (36), cardiovascular disease, ischemic stroke and heart failure (7, 37, 38).”
BackgroundClonal hematopoiesis is not significantly associated with COVID-19 disease severity
Zhou, Y., Shalhoub, R. N., Rogers, S. N., Yu, S. J., Gu, M., Fabre, M. A., Quirós, P. M., Shin, T., Diangson, A., Deng, W., et al. (2022) · Blood · doi:10.1182/blood.2022015721 · Cited by 23
“CH is associated with an increased risk of hematologic malignancies, but also of cardiovascular disease (CVD), independently of other known CVD risk factors.(11,12) The basis for this increased CVD risk has been linked to hyperinflammatory positive feedback loops driven by increased cytokine release from clonal myeloi…”
Negative Impact of TET2 Mutations on Long-Term Survival After Transcatheter Aortic Valve Replacement
Lassalle, F., Duployez, N., Vincent, F., Rauch, A., Denimal, T., Rosa, M., Labreuche, J., Dombrowicz, D., Staels, B., Preudhomme, C., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.04.010 · Cited by 22
Franch‐Expósito, S., Mehine, M. M., Ptashkin, R. N., Bolton, K. L., Bandlamudi, C., Srinivasan, P., Zhang, L., Goodell, M. A., Gedvilaite, E., Menghrajani, K. N., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.23.00070 · Cited by 23
Rotz, S. J., Bhatt, N. S., Hamilton, B. K., Duncan, C., Aljurf, M. D., Atsuta, Y., Beebe, K. L., Buchbinder, D. K., Burkhard, P., Carpenter, P. A., et al. (2024) · Bone Marrow Transplantation · doi:10.1038/s41409-023-02190-2 · Cited by 27
“Theclonal expansion of hematopoietic progenitors in CHIP appears to be due to age-associated somatic mutation, without overt hematologic malignancy [28 – 30].”
Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients
Singh, J. A., & Cleveland, J. D. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1606-z · Cited by 21
Smc3 is required for mouse embryonic and adult hematopoiesis
Wang, T., Glover, B. K., Hadwiger, G., Miller, C. A., di Martino, O., & Welch, J. S. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.11.008 · Cited by 24
The evolving role of next generation sequencing in myelodysplastic syndromes
Spaulding, T. P., Stockton, S. S., & Savona, M. R. (2019) · British Journal of Haematology · doi:10.1111/bjh.16212 · Cited by 21
Drofenik, A. A., Vrtovec, M., Mijovski, M. B., Sever, M., Zupan, I. P., Kejžar, N., & Blinc, A. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.01.001 · Cited by 21
Bаzyка, D., HATCH, M. C., Gudzenko, N., Cahoon, E. K., Drozdovitch, V., Little, M. P., Chumak, V. V., Bakhanova, E. V., Belyi, D., Kryuchkov, V., et al. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa095 · Cited by 21
“It can increase risk of cardiovascular disease (36) and hematological malignancies (37).”
BackgroundClonal Hematopoiesis of Indeterminate Potential in Crohn’s Disease and Ulcerative Colitis
Selvan, M. E., Nathan, D. I., Guisado, D., Collatuzzo, G., Iruvanti, S., Boffetta, P., Mascarenhas, J. O., Hoffman, R., Cohen, L. J., Marcellino, B. K., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae312 · Cited by 24
A genetic map of human metabolism across the allele frequency spectrum
Zoodsma, M., Beuchel, C. F., Yasmeen, S., Kohleick, L., Nepal, A., Koprulu, M., Kronenberg, F., Mayr, M., Williamson, A., Pietzner, M., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02355-3 · Cited by 28
“Variation in JAK2 predisposes to somatic mutations inducing hematopoiesis of indeterminate potential (CHIP) 29 , but other studies linked the gene product Janus kinase 2 (JAK2) to metabolism in liver 30 , adipocytes 31 or macrophages 32 .”
Importance of clonal hematopoiesis in heart failure
Chavkin, N. W., Min, K.-D., & Walsh, K. X. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.04.005 · Cited by 20
Somatic Mosaicism in Biology and Disease
Ogawa, H., Horitani, K., Izumiya, Y., & Sano, S. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061121-040048 · Cited by 23
Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms
Papageorgiou, L., Elalamy, I., Dreden, P. V., & Gerotziafas, G. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296221097969 · Cited by 29
Kuhnert, S., Mansouri, S., Rieger, M. A., Savai, R., Avcı, E., Díaz-Piña, G., Padmasekar, M., Looso, M., Hadžić, S., Acker, T., et al. (2022) · Cells · doi:10.3390/cells11132121 · Cited by 21
“As a possible indicator of CHIP mutations [3], we evaluated differences in proinflammatory cytokine formation and lung function between CHIP-positive and CHIP-negative”
BackgroundSega, F. V. D., Palumbo, D., Fortini, F., D’Agostino, Y., Cimaglia, P., Marracino, L., Severi, P., Strianese, O., Tarallo, R., Nassa, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24130-8 · Cited by 21
Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease
Buttner, P. G., Böttner, J., Krohn, K., Baber, R., Platzbecker, U., Cross, M. A., Desch, S., Thiele, H., Steiner, S., Scheinert, D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043962 · Cited by 20
“Interestingly, irrespective of CH, IL-1β inhibitors have already been found to improve cardiovascular outcomes in patients with stable coronary artery disease [30].”
BackgroundInfluentialMangaonkar, A. A., & Patnaik, M. M. (2023) · American Journal of Hematology · doi:10.1002/ajh.26915 · Cited by 25
“0001).(8) CH mutations (TET2 or DNMT3A, HR 2.”
BackgroundSum, H., & Brewer, A. C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1183181 · Cited by 21
Mangione, M. C., Wen, J., & Cao, D. J. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.10.011 · Cited by 23
Desai, P. M., Zhou, Y., Grenet, J. E., Handelman, S. K., Crispino, C., Tarbay, L. N., Whitsel, E. A., Roboz, G. J., Barac, A., Honigberg, M. C., et al. (2024) · Cancer · doi:10.1002/cncr.35455 · Cited by 21
“2,6,7 16 CHIP and mCAs can coexist in certain individuals and are linked with increased risk for hematological cancers compared to having either CHIP or mCA alone.”
Self-citationInflammation in myelodysplastic syndrome pathogenesis
Rodríguez‐Sevilla, J. J., & Colla, S. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.09.005 · Cited by 20
Sun, Y., Yu, Y., Cai, L., Yu, B., Xiao, W., Tan, X. W., Wang, Y., Lu, Y., & Wang, N. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02626-7 · Cited by 24
“In addition to its potential as a premalignant state in hematologic malignancy, CHIP has also been recognized as a novel risk factor for a variety of health outcomes, including diabetes [7] and CVD [8, 9].”
Disordered haematopoiesis and cardiovascular disease: a focus on myelopoiesis
Dragoljevic, D., Westerterp, M., Veiga, C. B., Nagareddy, P. R., & Murphy, A. J. (2018) · Clinical Science · doi:10.1042/cs20180111 · Cited by 22
Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
Gjini, E., Jing, C., Nguyen, A. T., Reyon, D., Gans, E., Kesarsing, M., Peterson, J. C., Pozdnyakova, O., Rodig, S. J., Mansour, M. R., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.035790 · Cited by 20
“Importantly, this age-related defect predisposes to the development of hematologic malignancy (Corces-Zimmerman et al., 2014; Hirsch et al., 2016; Shlush et al., 2014) and more recently was related to a doubling of the risk of coronary artery disease (Jaiswal et al., 2017).”
BackgroundJiang, D., Wang, Y., Chang, G., Duan, Q., You, L., Sun, M., Hu, C., Gao, L., Wu, S., Tao, H., et al. (2019) · Aging · doi:10.18632/aging.101972 · Cited by 20
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms
Chiriacò, M., Georgiopoulos, G. A., Duranti, E., Antonioli, L., Puxeddu, I., Nannipieri, M., Rosada, J., Blandizzi, C., Taddei, S., Virdis, A., et al. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00331-7 · Cited by 22
Huang, A. Y., Zhou, Z., Talukdar, M., Miller, M. B., Chhouk, B., Enyenihi, L., Rosen, I., Stronge, E., Zhao, B., Kim, D., et al. (2024) · doi:10.1101/2024.01.03.574078 · Cited by 16
Huang, A. Y., Zhou, Z., Talukdar, M., Enyenihi, L., Miller, M. B., Chhouk, B., Rosen, I., Zheng, M., Zhou, M., Yang, A., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.040 · Cited by 15
“19 Clonal expansion of blood cells, called clonal hematopoiesis (CH), increases in prevalence with age and is associated with increased risk of hematologic malignancies, but also unexpectedly with increased risk of cardiovascular disease, 20,21 likely through inflammatory effects of mutant cells.”
Metadata
- Authors
- Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., Baber, U., Mehran, R., Fuster, V., Danesh, J., Frossard, P., Saleheen, D., Melander, O., Sukhova, G. K., Neuberg, D., Libby, P., Kathiresan, S., & Ebert, B. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- ORCID
- Jaiswal, Siddhartha
- Natarajan, Pradeep
- Silver, Alexander J.
- Gibson, Christopher J.
- Bick, Alexander G.
- McConkey, Marie
- Gupta, Namrata
- Gabriel, Stacey
- Ardissino, Diego
- Baber, Usman
- Mehran, Roxana
- Danesh, John
- Saleheen, Danish
- Melander, Olle
- Sukhova, Galina K.
- Neuberg, Donna
- Libby, Peter
- Kathiresan, Sekar
- Ebert, Benjamin L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-07-13
- Volume
- 377
- Issue
- 2
- Pages
- 111-121
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6717509
- OpenAlex
- W2628145035
- Cited by
- 2,683
- References
- 37
- Citations by year
- 2026: 303 · 2025: 322 · 2024: 347 · 2023: 338 · 2022: 371 · 2021: 303 · 2020: 263 · 2019: 215 · 2018: 169 · 2017: 44
- FWCI
- 143.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/014/24067)
- Novo Nordisk Fonden (NNF14OC0009819, NNF13OC0005339)
- Medical Research Council (MR/L003120/1)
- National Heart, Lung, and Blood Institute (R01HL082945, R01HL080472, RC2HL101834, T32HL116324)
- National Human Genome Research Institute (U54HG003067)
- Fogarty International Center (RC1TW008485)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- clonal hematopoiesis of indeterminate potential, atherosclerotic cardiovascular disease, coronary artery disease, myocardial infarction, coronary artery calcification, TET2 mutation, DNMT3A, ASXL1, JAK2, somatic mutations, atherosclerosis, cytokines and chemokines, macrophages, bone marrow transplantation
- MeSH terms
- Animals, Coronary Disease, Hematopoiesis, Hematopoietic Stem Cells, Humans, Mutation, Risk, Case-Control Studies, Sequence Analysis, DNA, Mice, Knockout, Genetic Predisposition to Disease, Atherosclerosis, Mice, Exome, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.